Evolus issues preliminary Q4 and full-year 2025 revenue results

Evolus (NASDAQ:EOLS), a global performance beauty company dedicated to building a differentiated aesthetic portfolio, announced preliminary, unaudited net revenue results for the fourth quarter and full year ended December 31, 2025, along with updated forward-looking guidance.

Fourth-quarter net revenue is expected in the range of $88.6 million to $90.6 million, representing 12% to 15% growth over the prior-year period.

The company reaffirmed achievement of a key milestone with positive non-GAAP operating income of $5 million to $7 million in the fourth quarter.

For the full year 2025, preliminary net revenue is anticipated to be between $295.5 million and $297.5 million, reflecting 11% to 12% growth compared with 2024.

Looking ahead, Evolus provided 2026 net revenue guidance of $327 million to $337 million, implying 11% to 13% growth from the midpoint of its preliminary 2025 results.

Management reiterated its expectation to achieve sustainable annual profitability beginning in 2026.

The company also updated its long-term financial outlook for 2028, now targeting total net revenue of $450 million to $500 million, representing a three-year compound annual growth rate of 15% to 19% from the midpoint of 2026 guidance.

Non-GAAP operating income margins are projected to reach 13% to 15% in 2028.